CNNMoney.com -
USA
Clinical trials of Pfizer/Ligand Pharmaceuticals' Fablyn drug to treat osteoporosis in postmenopausal women showed a lower risk that patients would develop spine fractures compared to a placebo.
...
See all stories on this topic
Acucela
and Otsuka Pharmaceutical Enter Co-Development Agreement
... 4:55 AM 9/4/2008
MarketWatch -
USA
Acucela Inc and Otsuka Pharmaceutical Co have entered into an agreement to co-develop Rebamipide ophthalmic suspension. Rebamipide is Otsuka's treatment of dry eye currently in Phase III clinical development in the US.
...
See all stories on this topic
Regeneron's drug to lower gout flares meets goal 3:04 PM 9/3/2008
Reuters - USA
Regeneron Pharmaceuticals Inc said its experimental drug Arcalyst to reduce gout flares met the main goal in a mid-stage trial.
...
See all stories on this topic
Pfizer gains
rights to Medivation Alzheimer's drug 8:44 AM 9/3/2008
Reuters - USA
Pfizer Inc is acquiring rights to the drug Dimebon for Alzheimer's disease from Medivation Inc. Dimebon is also being developed for Huntington's disease.
...
See all stories on this topic
Alexza schizophrenia drug meets main goal; shares rise 4:01 PM 9/2/2008
Reuters - USA
Alexza Pharmaceuticals Inc said its drug AZ-004 for the treatment of schizophrenia met the main goal of a late-stage clinical trial. AZ-004 is an inhalation product being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder.
...
See all stories on this topic
Schering-Plough,
Merck's Vytorin Sales May Fall Again 3:31 PM 9/2/2008
Bloomberg - USA
Schering-Plough Corp and Merck & Co may see sales of their cholesterol drug Vytorin drop even further after it was linked to cancer deaths in a three-study analysis intended to reassure patients.
...
See all stories on this topic
GlaxoSmithKline
cuts some ties to bowel drug 1:22 PM 9/2/2008
Bizjournals.com - Charlotte,NC,USA
GlaxoSmithKline has scaled back its development agreement with Adolor Corp for the gastrointestinal drug Entereg.
...
See all stories on this topic
Alpharma
says FDA accepts new drug application for Embeda capsules 8:57 AM 9/2/2008
Forbes - NY,USA
Alpharma Inc said the US FDA accepted its new drug application for Embeda capsules with priority review status.
...
See all stories on this topic
Merck's
Singulair Not Linked to Depression, Suicide, Study Says 5:37 AM 9/2/2008
Bloomberg - USA
Researchers found no evidence to support regulatory warnings that Merck & Co's Singulair asthma and allergy drug may be linked to depression or suicide.
...
See all stories on this topic
Japan
drug firm bids $1.1 billion for US rival 6:30 AM 9/1/2008
International Herald Tribune - France
Shionogi plans to buy US-based Sciele Pharma for $1.1 billion. This follows acquisitions by Takeda Pharmaceutical, Daiichi Sankyo, and Eisai aimed at building sales networks in the United States.
...
See all stories on this topic
Prasugrel
Head-to-Head Study Showed Reduced Cardiovascular Events
... 2:20 AM 9/1/2008
MarketWatch -
USA
Diabetic patients dagnosed with acute coronary syndromes (ACS) were 40 percent less likely to suffer a heart attack if they were treated with prasugrel vs. clopidogrel
. ...
See all stories on this topic
Bayer
accelerates development of key drug Xarelto 7:26 AM 8/31/2008
Reuters - USA
Bayer AG will accelerate the development program for its anticoagulant Xarelto.
...
See all stories on this topic
Novartis
halts development of antibiotic drug 5:18 AM 8/29/2008
MarketWatch - USA
Novartis said it's going to halt development of Aurograb which it gained the rights to by buying NeuTec Pharma in 2006. A recently completed Phase II trial showed the drug doesn't work.
...
See all stories on this topic
<- Earlier Stories | Topics Recently In the News
See All
